newsfilter
← Latest News
Business Wire·

Forte Biosciences, Inc. Announces Results and Provides Update

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ:FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its first quarter 2025 financial results and